Advancing INM-901 as a multimodal treatment option for Alzheimer’s Disease Advancing INM-089 in the treatment of Age-related Macular Degeneration Actively seeking partnerships to advance INM-755 in Dermatology BayMedica subsidiary continues… Read More
This month, a group of stroke survivors in B.C. will test a new technology designed to aid their recovery, and ultimately restore use of their limbs and hands. Participants will… Read More
Q1 Fiscal 2024 Highlights Gross profit of $2.1 million, an 18.8% increase over Q4 2023 Revenue of $5.9 million, a 3.0% decline over Q4 2023 Reduced operating expenditures of 19.9% over Q4… Read More
Getinge will issue its Year-End Report 2023 on February 1, 2024, at 08:00 a.m. CET, followed by a conference call at 10:00 a.m. CET, hosted by Mattias Perjos, President &… Read More
OTTAWA, ON – With the release of their National Compensation Guide, BioTalent Canada is helping health and biosciences employers develop a robust talent management strategy to improve their recruitment and… Read More
